ARTICLE | Company News
Compugen, DiagnoCure deal
January 22, 2002 8:00 AM UTC
The companies will develop and commercialize molecular diagnostic tests to detect certain epithelial cancers including lung cancer. CGEN will identify disease markers for use by CUR in developing diag...